Boardroom Alpha
8-K primary document
GGT-PE · Current Report (Form 8-K) · Filed February 20, 2026

Gabelli Multimedia Trust Inc8-K exhibit

gabellimultimedia_ex1-1.htm

 

Exhibit 1.1

 

The Gabelli Multimedia Trust Inc.

 

AMENDMENT NO. 2
to

SALES AGREEMENT

Dated April 16, 2025

 

Common Stock

Par Value $0.001 Per Share

 

February 20, 2026

 

G. Rearch, LLC
One Corporate Center
Rye, New York 10580

 

Ladies and Gentlemen:

 

The Gabelli Multimedia Trust Inc. (the “Fund”), a Maryland corporation, Gabelli Funds, LLC, a New York limited liability company (the “Investment Adviser”) and G.research, LLC (the “Sales Manager”), as agent, previously entered into that certain Sales Agreement, dated April 16, 2025 (the “Original Agreement”), in connection with the issuance and sale of as much as $22,350,000 aggregate value of common stock, par value $0.001 per share (the “Common Shares”), or 5,000,000 Common Shares, of the Fund, as amended by Amendment No. 1 to the Sales Agreement, dated October 10, 2025 (as so amended, the “Amended Agreement”). This Amendment No. 2 to the Sales Agreement (this “Amendment”) amends certain provisions of the Amended Agreement, subject to the execution and delivery by the parties hereto of this Amendment. Capitalized terms not defined herein shall have the meanings assigned to them in the Original Agreement.

 

In consideration of the premises and of the mutual covenants and agreements contained herein and in the Original Agreement, the Fund, the Investment Adviser and the Sales Manager hereby agree that the Original Agreement be amended as follows:

 

The Maximum Amount of Common Shares shall be $75,990,000, or 17,000,000 Common Shares. The Fund agrees to issue and sell through the Sales Manager, as agent, and the Sales Manager agrees to sell, as agent for the Fund, on a best efforts basis up to the Maximum Amount of the Common Shares during the term of the Sales Agreement, as amended hereby, on the terms set forth in the Original Agreement, as amended or supplemented from time to time.

 

 

 

If the foregoing correctly sets forth the understanding among the Fund, the Investment Adviser and the Sales Manager, please so indicate in the space provided below, whereupon this Amendment and your acceptance shall constitute a binding agreement among the Fund, the Investment Adviser and the Sales Manager.

 

  Sincerely,
     
  THE GABELLI MULTIMEDIA TRUST INC.
   
  /s/ John C. Ball
  By: John C. Ball
  Title: President

 

  GABELLI FUNDS, LLC
   
  /s/ John C. Ball
  By: John C. Ball
  Title: Chief Operating Officer

 

Accepted and agreed to as of
the date first above written, on behalf of itself

 

G.research, LLC  
   
/s/ Vincent Amabile  
By: Vincent Amabile  
Title: Chief Executive Officer  

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer